Annals of Laboratory Medicine

Korean Society for Laboratory Medicine (대한진단검사의학회)
권호 표지
DOI QR코드

DOI QR Code

Clonal Spread of Carbapenem Non-susceptible Acinetobacter baumannii in an Intensive Care Unit in a Teaching Hospital in China

  • Zhong, Qiao (Department of Laboratory Medicine, Suzhou Municipal Hospital Affiliated Nanjing Medical University) ;
  • Xu, Weidong (Department of Laboratory Medicine, Suzhou Municipal Hospital Affiliated Nanjing Medical University) ;
  • Wu, Yuanjian (Department of Laboratory Medicine, Suzhou Municipal Hospital Affiliated Nanjing Medical University) ;
  • Xu, Hongxing (Department of Laboratory Medicine, Suzhou Municipal Hospital Affiliated Nanjing Medical University)
  • Published : 2012.11.01
⟨ Previous Next ⟩

Abstract

Background: This study was aimed to investigate the genetic diversity and antibiotic resistance profile of the nosocomial infection agent Acinetobacter baumannii from a medical intensive care unit (ICU) in a teaching hospital in Suzhou, China. Methods: The genetic relationship among A. baumannii isolates in an ICU was investigated using multilocus sequence typing (MLST). The antibiotic resistance pattern was determined by performing an antibiotic susceptible test, which included an agar dilution method and an E-test method. Resistant determinants, e.g., carbapenemase genes, metallo-${\beta}$-lactamases, and class 1 integron, were analyzed by specific PCR and DNA sequencing. Results: In the present study, 33 non-duplicate isolates were identified as 5 existing sequence types (STs) (ST92, ST75, ST112, ST145, and ST345) and 1 new sequence type STn, which has a G-A mutation at nt268 on ropD40 of ST251. These results reveal limited diversity in carbapenem non-susceptible A. baumannii (CNSAb) isolates in our ICU, which are comprised of only 2 distinct STs, with ST92 and ST75 clustering into a clonal complex (CC) 92. Most CNSAb isolates (94.4%, 17/18) harbored the OXA-23 gene, while no carbapenem-susceptible A. baumannii (CSAb) isolates harbored it. In addition, 66.7% (22/33) isolates were positive for class 1 integrase, and gene cassette analysis showed there are 3 gene arrays among them, i.e., aacA4-catB8-aadA1 (77.3%, 17/22), aacA4 (22.7%, 5/22), and aacC1-orfX-orfX'-aadA1 (4.5%, 1/22). Conclusions: When all these data are combined, the antibiotic resistance and wide distribution of CNSAb isolates in our ICU are probably caused by expansion of the CC92 clone.

Keywords

References

  1. Joly-Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect 2005;11:868-73. https://doi.org/10.1111/j.1469-0691.2005.01227.x
  2. Abbo A, Navon-Venezia S, Hammer-Muntz O, Krichali T, Siegman-Igra Y, Carmeli Y. Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis 2005;11:22-9. https://doi.org/10.3201/eid1101.040001
  3. Piazza O, Iasiello A, PapaIanni C, De Robertis E, Servillo G, Rossano F, et al. Incidence of antimicrobial-resistant ventilator associated pneumonia: an eighteen-month survey. Panminerva Med 2005;47:265-7.
  4. Wu CJ, Lee HC, Lee NY, Shih HI, Ko NY, Wang LR, et al. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003. J Microbiol Immunol Infect 2006;39:135-43.
  5. Jeon BC, Jeong SH, Bae IK, Kwon SB, Lee K, Young D, et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in korea. J Clin Microbiol 2005;43:2241-5. https://doi.org/10.1128/JCM.43.5.2241-2245.2005
  6. Lee K, Yum JH, Yong D, Lee HM, Kim HD, Docquier JD, et al. Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 2005;49:4485-91. https://doi.org/10.1128/AAC.49.11.4485-4491.2005
  7. Poirel L, Marque S, Heritier C, Segonds C, Chabanon G, Nordmann P. OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother 2005;49:202-8. https://doi.org/10.1128/AAC.49.1.202-208.2005
  8. Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006;258:72-7. https://doi.org/10.1111/j.1574-6968.2006.00195.x
  9. Brown S, Young HK, Amyes SG. Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin Microbiol Infect 2005;11:15-23.
  10. Merkier AK and Centron D. Bla(OXA-51)-type beta-lactamase genes are ubiquitous and vary within a strain in Acinetobacter baumannii. Int J Antimicrob Agents 2006;28:110-3. https://doi.org/10.1016/j.ijantimicag.2006.03.023
  11. Zhou H, Pi BR, Yang Q, Yu YS, Chen YG, Li LJ, et al. Dissemination of imipenem-resistant Acinetobacter baumannii strains carrying the ISA-ba1 blaOXA-23 genes in a Chinese hospital. J Med Microbiol 2007;56:1076-80. https://doi.org/10.1099/jmm.0.47206-0
  12. White PA, McIver CJ, Rawlinson WD. Integrons and gene cassettes in the enterobacteriaceae. Antimicrob Agents Chemother 2001;45:2658-61. https://doi.org/10.1128/AAC.45.9.2658-2661.2001
  13. Gu B, Tong M, Zhao W, Liu G, Ning M, Pan S. Prevalence and characterization of class I integrons among Pseudomonas aeruginosa and Acinetobacter baumannii isolates from patients in Nanjing, China. J Clin Microbiol 2007;45:241-3. https://doi.org/10.1128/JCM.01318-06
  14. Fu Y, Zhou J, Zhou H, Yang Q, Wei Z, Yu Y, et al. Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China. J Antimicrob Chemother 2010;65:644-50. https://doi.org/10.1093/jac/dkq027
  15. He C, Xie Y, Zhang L, Kang M, Tao C, Chen Z, et al. Increasing imipenem resistance and dissemination of the ISAba1-associated blaOXA-23 gene among Acinetobacter baumannii isolates in an intensive care unit. J Med Microbiol 2011;60:337-41. https://doi.org/10.1099/jmm.0.022681-0
  16. Adams-Haduch JM, Onuoha EO, Bogdanovich T, Tian GB, Marschall J, Urban CM, et al. Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States. J Clin Microbiol 2011;49:3849-54. https://doi.org/10.1128/JCM.00619-11
  17. Chang HC, Wei YF, Dijkshoorn L, Vaneechoutte M, Tang CT, Chang TC. Species-level identification of isolates of the Acinetobacter calcoaceticus- Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J Clin Microbiol 2005;43:1632-9. https://doi.org/10.1128/JCM.43.4.1632-1639.2005
  18. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals, 3rd ed., approved standard M31-A3. CLSI, Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
  19. Lee K, Lim YS, Yong D, Yum JH, Chong Y. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2003;41:4623-9. https://doi.org/10.1128/JCM.41.10.4623-4629.2003
  20. Bartual SG, Seifert H, Hippler C, Luzon MA, Wisplinghoff H, Rodriguez-Valera F. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol 2005;43:4382-90. https://doi.org/10.1128/JCM.43.9.4382-4390.2005
  21. Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol 2004;186:1518-30. https://doi.org/10.1128/JB.186.5.1518-1530.2004
  22. Wang F, Zhu D, Hu F, Ruan F, Ni Y, Sun J, et al. CHINET 2007 surveillance of bacterial resistance in China. Chinese Journal of Infection and Chemotherapy (Chinese) 2008;8:325-34.
  23. Zhang L, Yang W, Xiao M, Xu Y, Zheng B, Lü Y. Mohnarin annual report 2010:surveillance of antimicrobial resistance in bacteria isolated from intensive care units. Chinese Journal of Nosocomiology 2012;28:330-5.
  24. Zhang JP, Zhu W, Chu YZ, Tian SF, Chen BY. Molecular epidemiological study of multi-drug resistant Acinetobacter baumannii (Chinese). Zhonghua Nei Ke Za Zhi 2010;49:657-61.
  25. Grosso F, Carvalho KR, Quinteira S, Ramos A, Carvalho-Assef AP, Asensi MD, et al. OXA-23-producing Acinetobacter baumannii: a new hotspot of diversity in Rio de Janeiro? J Antimicrob Chemother 2011;66:62-5. https://doi.org/10.1093/jac/dkq406
  26. Wang H, Guo P, Sun H, Yang Q, Chen M, Xu Y, et al. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob Agents Chemother 2007;51:4022-8. https://doi.org/10.1128/AAC.01259-06
  27. Lei J, Yuan L, Li H, Zeng X. Study of metallo-${\beta}$-lactamase of Carbapenems- resistant Acinetobacter baumanii. Modern Journal of Integrated Traditional Chinese and Western Medicine 2009;27:3280-1.
  28. Dawes FE, Kuzevski A, Bettelheim KA, Hornitzky MA, Djordjevic SP, Walker MJ. Distribution of class 1 integrons with IS26-mediated deletions in their 3'-conserved segments in Escherichia coli of human and animal origin. PLoS One 2010;5:e12754. https://doi.org/10.1371/journal.pone.0012754
  29. Moura A, Soares M, Pereira C, Leitao N, Henriques I, Correia A. INTEGRALL: a database and search engine for integrons, integrases and gene cassettes. Bioinformatics 2009;25:1096-8. https://doi.org/10.1093/bioinformatics/btp105
  30. Xu X, Kong F, Cheng X, Yan B, Du X, Gai J, et al. Integron gene cassettes in Acinetobacter spp. strains from South China. Int J Antimicrob Agents 2008;32:441-5. https://doi.org/10.1016/j.ijantimicag.2008.05.014
  31. Hornsey M, Loman N, Wareham DW, Ellington MJ, Pallen MJ, Turton JF, et al. Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy. J Antimicrob Chemother 2011;66:1499-503. https://doi.org/10.1093/jac/dkr168
  32. Fournier PE, Vallenet D, Barbe V, Audic S, Ogata H, Poirel L, et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2006;2:e7. https://doi.org/10.1371/journal.pgen.0020007
  33. Zhou H, Zhang T, Yu D, Pi B, Yang Q, Zhou J, et al. Genomic analysis of the multidrug-resistant Acinetobacter baumannii strain MDR-ZJ06 widely spread in China. Antimicrob Agents Chemother 2011;55:4506-12. https://doi.org/10.1128/AAC.01134-10
  34. Krizova L, Dijkshoorn L, Nemec A. Diversity and evolution of AbaR genomic resistance islands in Acinetobacter baumannii strains of European clone I. Antimicrob Agents Chemother 2011;55:3201-6. https://doi.org/10.1128/AAC.00221-11
  35. Ruiz-Martinez L, Lopez-Jimenez L, Fuste E, Vinuesa T, Martinez JP, Vinas M. Class 1 integrons in environmental and clinical isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents 2011;38:398-402. https://doi.org/10.1016/j.ijantimicag.2011.06.016

Cited by

  1. Effects of a combination of amlodipine and imipenem on 42 clinical isolates of Acinetobacter baumannii obtained from a teaching hospital in Guangzhou, China vol.13, pp.None, 2012, https://doi.org/10.1186/1471-2334-13-548
  2. Molecular Epidemiology of Integron-Associated Antimicrobial Gene Cassettes in the Clinical Isolates of Acinetobacter baumannii from Northern Taiwan vol.33, pp.4, 2013, https://doi.org/10.3343/alm.2013.33.4.242
  3. Comparative study of different molecular methods for typing of Acinetobacter baumannii clinical isolates from University Hospitals vol.36, pp.5, 2012, https://doi.org/10.1007/s13258-014-0183-z
  4. Molecular Epidemiology and Mechanisms of Tigecycline Resistance in Clinical Isolates of Acinetobacter baumannii from a Chinese University Hospital vol.58, pp.1, 2012, https://doi.org/10.1128/aac.01727-13
  5. Tracing the emergence of multidrug-resistant Acinetobacter baumannii in a Taiwanese hospital by evaluating the presence of integron gene intI1 vol.13, pp.1, 2012, https://doi.org/10.1186/1477-5751-13-15
  6. Genetic Characterization of ST195 and ST365 Carbapenem-Resistant Acinetobacter baumannii Harboring blaOXA-23 in Guangzhou, China vol.21, pp.4, 2012, https://doi.org/10.1089/mdr.2014.0183
  7. The resistance and transmission mechanism ofAcinetobacter baumanniiisolates in a tertiary care hospital, China vol.28, pp.6, 2012, https://doi.org/10.1080/1120009x.2016.1139335
  8. Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality vol.17, pp.None, 2012, https://doi.org/10.1186/s12879-017-2471-0